Congress Speakers

  • Professor Ari Zimran, Israel I Congress Chair

    Professor Ari Zimran, Israel I Congress Chair

    Professor Ari Zimran is Director of the Gaucher Clinic at Shaare Zedek Medical Center in Jerusalem, Israel. This is the world’s largest referral centre for Gaucher disease, where more than 750 patients are followed and about 350 patients are treated with enzyme replacement therapy. 
  • Gheona Altarescu, Israel

    Gheona Altarescu, Israel

    Gheona Altarescu obtained her magna cum laude diploma in Medicine at the Jassy University of Medicine and Pharmacy, Romania. She performed her training in  medical genetics at the National Institutes of Health, Bethesda, USA during the years 1997 to 2000 under the supervision of Dr. Roscoe Brady. 
  • David Arkadir, Israel

    David Arkadir, Israel

    David Arkadir, MD PhD, was trained as a neurologist at Hadassah Medical Center (Jerusalem, Israel), and as a Movement Disorders specialist at Columbia University Medical Center (NY, USA), under the supervision of Dr. Stanley Fahn. 
  • Michael Beck, Germany

    Michael Beck, Germany

    Prof. Michael Beck received pediatric training at the Department of Pediatrics of the University of Frankfurt and training in genetics at the Institute of Human Genetics in Frankfurt/M. From 1980 to 2013 he has been a consultant at the Children`s Hospital of the University of Mainz.

  • Carlo Brugnara, USA

    Carlo Brugnara, USA

    Dr. Carlo Brugnara, MD is Professor of Pathology at Harvard Medical School and Director of the Hematology Laboratory at Boston Children’s Hospital.  He received his MD from the University of Verona, Italy and trained in Clinical Pathology and Transfusion Medicine at Brigham and Women’s Hospital in Boston, and holds board certifications in both specialties.

  • Gabriel Cohn, USA

    Gabriel Cohn, USA

    Dr Gabriel Cohn is board certified in Clinical Genetics and OBGYN and is VP of Clinical Development at AVROBIO. He’s held roles at Shire and OVASCIENCE, spanning Medical Affaris, Translational Medicine, and Clinical Development.
  • Madeline, Collin, UK

    Madeline, Collin, UK

    Madeline Collin, now twenty-four years old was diagnosed with Type III Gaucher disease in 1996 and currently lives in Bath where she is studying for an MSc in International Development, Social Justice and Sustainability. 
  • Tanya Collin-Histed, UK

    Tanya Collin-Histed, UK

    Tanya Collin-Histed became involved in the Gaucher world in 1996 when her daughter Maddie was diagnosed with Type 3 Gaucher disease. A year later she became a Trustee for the UK Gauchers Association and started to support patients and their families with Type II and III Gaucher Disease through family conferences, information booklets and proving friendship and emotional support.
  • Elin Haf Davies, UK

    Elin Haf Davies, UK

    Elin initially qualified as a Children’s nurse at Great Ormond St Children’s Hospital, going on to gain a BSc (Neuroscience) and MSc (Research Methods). After years of recruiting children to clinical trials Elin embarked on a PhD at the Institute of Child Health (UCL) to develop a clinical outcome measure and biomarker of ataxia in children with neuro-metabolic disease. 
  • Deborah Elstein, Israel

    Deborah Elstein, Israel

    Deborah Elstein was Coordinator of Clinical Research at the Gaucher Clinic in Shaare Zedek Medical Center in Jerusalem from 1993-2016. She has authored >250 papers and book chapters with clinical observations and basic research, as well as having been involved in seminal clinical trials for new drugs for Gaucher disease.
  • Dominique Germain, France

    Dominique Germain, France

    Professor Germain graduated in medicine, from the University of Nancy I, France, where he received his doctorate in medicine (MD). He then completed a doctorate in human genetics (PhD) at the University Paris VII (Denis Diderot) France. He obtained his Habilitation (Habilitation à Diriger les Recherches, HDR) in 2005 from the University Paris V (René Descartes). 
  • Edward Ginns, USA

    Edward Ginns, USA

    Dr. Edward Ginns, Professor and Director of the Lysosomal Disorders Treatment and Research Program at University of Massachusetts Medical School, Worcester, MA, is board certified in Neurology. He earned his medical degree from Johns Hopkins School of Medicine and completed Neurology residency at Albert Einstein College of Medicine, NY.  
  • Amos Korczyn, Israel

    Amos Korczyn, Israel

    Professor Amos D. Korczyn is the Sieratzki Professor of Neurology at Tel-Aviv University.  He is the Chairman of the Department of Neurology at the Tel-Aviv Medical Center since 1981.  Professor Korczyn graduated from the Hebrew University – Hadassah Medical School in Jerusalem in 1966, where he also received an M.Sc degree in pharmacology (cum laude). 
  • Florian Lagler, Austria

    Florian Lagler, Austria

    Florian B Lagler is a Pediatrician and board-certified Pharmacologist and Toxicologist. He is a Clinical/Translational Researcher in the field of lysosomal storage diseases (LSDs) and other inborn errors of metabolism. 
  • Petra Muus, UK

    Petra Muus, UK

    Petra Muus established the National PNH Expert Centre in the Netherlands.  Her clinical and research interests are PNH, Bone Marrow Failure syndromes, Myelodysplastic Syndromes and Acute Leukaemia. Her PhD was on the Biological Basis for Resistance in Leukaemia.
  • Lucas Paletta, Austria

    Lucas Paletta, Austria

    Lucas Paletta is key researcher, project manager and head of the Human Factors Lab at JOANNEUM RESEARCH Forschungsgesellschaft mbH, Institute DIGITAL, Graz, Austria.
  • Uma Ramaswami, UK

    Uma Ramaswami, UK

    Uma Ramaswami is a Consultant in Inherited Metabolic Disorders based at the Lysosomal Disorders Unit (LSDU) at the Royal Free Hospital, London.
  • Arndt Rolfs, Germany

    Arndt Rolfs, Germany

    Arndt Rolfs, MD, Professor for Neurology and Psychiatry, is appointed CEO and founder of Centogene AG, and Director of the Albrecht-Kossel-Institute for Neuroregeneration at the University of Rostock, Germany. He received his approbation for human medicine in 1985 from the University of Mainz, Germany and the University of Vienna, Austria.
  • Varda Shalev, Israel

    Varda Shalev, Israel

    Prof. Varda Shalev, MD MPH, is the director of the institute of research and innovation Maccabitech (Big-data and Epidemiology research), and an active primary care physician in Maccabi Health Care Services. With an MD degree from Ben-Gurion University Medical School, she completed her residency in family medicine and earned an MPA in Public Health Administration at Clark University. 
  • Avraham Steinberg, Israel

    Avraham Steinberg, Israel

    Prof. Avraham Steinberg is an awardee of the Israel Prize Laureate. He is Associate Clinical Professor of Medical Ethics at Hebrew University-Hadassah Medical School, Jerusalem and Director of the Medical Ethics Unit, Shaare Zedek Medical Center, Jerusalem.
  • Thomas Stulnig, Austria

    Thomas Stulnig, Austria

    Professor Stulnig studied medicine at the university of Innsbruck, Austria, and holds an MBA in Health Care Management. He specialized in Internal medicine with focus on endocrinology and metabolic disease. Currently he is head of the clinic for Inborrn Disorders of Metabolism in the Adult at the Medical University Vienna. 
  • Jeff Szer, Australia

    Jeff Szer, Australia

    Jeff Szer was the foundation Professor/Director of the Department of Clinical Haematology at Royal Melbourne Hospital. 
  • Michael Wajnrajch, USA

    Michael Wajnrajch, USA

    Michael Wajnrajch is a board-certified pediatric endocrinologist.  He has worked at Pfizer since 2003, and currently is a Senior Medical Director in the Rare Diseases Global Medical Affairs group, responsible for Inborn Errors of Metabolism and Endocrinology at Pfizer.
  • Zeev Zelig, Israel

    Zeev Zelig, Israel

    Zeev is CEO of his consultancy firm servicing Multinational and Local companies in the life science field - Zeev Zelig Life Sciences Strategic Consulting LTD